"Long-lasting UTI Vaccine Provides 9 Years of Protection for Over Half of Recipients"

A study presented at the European Association of Urology Congress reveals that the MV140 vaccine, administered as an oral spray, has shown to prevent urinary tract infections (UTIs) for up to 9 years in 54% of participants, with an average infection-free period of 4.5 years. The vaccine, containing inactivated whole bacteria of major UTI-causing species, has been well-tolerated and resulted in fewer and less severe UTIs. Researchers believe it could be a game changer for UTI prevention and reduce the reliance on antibiotic treatments, with further research needed to optimize its use.